[1] |
VOGRIG A, GIGLI G L, BNÀ C,et al. Stroke in patients with COVID-19:clinical and neuroimaging characteristics[J]. Neurosci Lett, 2021, 743:135564. DOI: 10.1016/j.neulet.2020.135564.
|
[2] |
GUSEV E I, MARTYNOV M Y, BOYKO A N,et al. Novel coronavirus infection (COVID-19) and nervous system involvement:pathogenesis,clinical manifestations,organization of neurological care[J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2020, 120(6):7-16. DOI: 10.17116/jnevro20201200617.
|
[3] |
MEHTA P R, APAP MANGION S, BENGER M,et al. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination-a report of two UK cases[J]. Brain Behav Immun, 2021, 95:514-517. DOI: 10.1016/j.bbi.2021.04.006.
|
[4] |
DAVID C H, WAEL E, ELIZABETH R. COVID-19-related stroke[J]. Translational Stroke Research, 2020, 11(3):322-335. DOI: 10.1007/s12975-020-00818-9.
|
[5] |
PANDAIN J D, PANAGOS P D, SEBASTIAN I A,et al. Maintaining stroke care during the COVID-19 pandemic in lower- and middle-income countries:world stroke organization position statement endorsed by American Stroke Association and American Heart Association[J]. Stroke, 2022, 53(3):1043-1050. DOI: 10.1161/STR.0000000000000394.
|
[6] |
GOLOMB M R, HALL G C. Letter by golomb and hall regarding article,"temporary emergency guidance to US stroke centers during the COVID-19 pandemic" [J]. Stroke, 2020, 51(7):e138. DOI: 10.1161/STROKEAHA.120.030251.
|
[7] |
BAO Y, LIN S Y, CHENG Z H,et al. Clinical features of COVID-19 in a young man with massive cerebral hemorrhage-case report[J]. SN Compr Clin Med, 2020, 2(6):703-709. DOI: 10.1007/s42399-020-00315-y.
|
[8] |
SHIBATA K I, MUKAI T, NAKAGAKI H,et al. A case of cerebral embolism with coronavirus disease 2019[J]. Rinsho Shinkeigaku, 2021, 61(7):486-490. DOI: 10.5692/clinicalneurol.cn-001593.
|
[9] |
NG KEE KWONG K C, MEHTA P R, SHUKLA G,et al. COVID-19,SARS and MERS:a neurological perspective[J]. J Clin Neurosci, 2020, 77:13-16. DOI: 10.1016/j.jocn.2020.04.124.
|
[10] |
KONCZ J, OROSZ V, SULYOK Z,et al. Treatment options for enormous carotid thrombus as a complication of SARS-CoV-2 infection[J]. Ideggyogy Sz, 2021, 74(3/4):129-134. DOI: 10.18071/isz.74.0129.
|
[11] |
BALCOM E F, NATH A, POWER C. Acute and chronic neurological disorders in COVID-19:potential mechanisms of disease[J]. Brain, 2021, 144(12):3576-3588. DOI: 10.1093/brain/awab302.
|
[12] |
PAGE M J, MCKENZIE J E, BOSSUYT P M,et al. The PRISMA 2020 statement:an updated guideline for reporting systematic reviews[J]. Int J Surg, 2021, 88:105906. DOI: 10.1016/j.ijsu.2021.105906.
|
[13] |
HOERTEL N, SÁNCHEZ-RICO M, VERNET R,et al. Observational study of haloperidol in hospitalized patients with COVID-19[J]. PLoS One, 2021, 16(2):e0247122. DOI: 10.1371/journal.pone.0247122.
|
[14] |
|
[15] |
LANG S, KLEIJNEN J. Quality assessment tools for observational studies:lack of consensus[J]. Int J Evid Based Healthc, 2010, 8(4):247. DOI: 10.1111/j.1744-1609.2010.00195.x.
|
[16] |
DHAMOON M S, THALER A, GURURANGAN K,et al. Acute cerebrovascular events with COVID-19 infection[J]. Stroke, 2021, 52(1):48-56. DOI: 10.1161/STROKEAHA.120.031668.
|
[17] |
QURESHI A I, BASKETT W I, HUANG W,et al. Acute ischemic stroke and COVID-19:an analysis of 27 676 patients[J]. Stroke, 2021, 52(3):905-912. DOI: 10.1161/STROKEAHA.120.031786.
|
[18] |
KATZ J M, LIBMAN R B, WANG J J,et al. Cerebrovascular complications of COVID-19[J]. Stroke, 2020, 51(9):e227-231. DOI: 10.1161/STROKEAHA.120.031265.
|
[19] |
BHATIA R, SRIVASTAVA M V P, SYLAJA P N,et al. Clinical features and outcome of stroke with COVID-19. COVID-19 stroke study group (CSSG),India[J]. Ann Indian Acad Neurol, 2021, 24(5):668-685. DOI: 10.4103/aian.AIAN_122_21.
|
[20] |
MEHRPOUR M, SHUAIB A, FARAHANI M,et al. Coronavirus disease 2019 and stroke in Iran:a case series and effects on stroke admissions[J]. Int J Stroke, 2021, 16(9):1047-1052. DOI: 10.1177/1747493020937397.
|
[21] |
PABLO N,ISABEL R C,CECILIA R,et al. COVID-19 and ischemic stroke:clinical and neuroimaging findings[J]. J Neuroimaging,2020,31(1).
|
[22] |
MATHEW T, JOHN S K, SARMA G,et al. COVID-19-related strokes are associated with increased mortality and morbidity:a multicenter comparative study from Bengaluru,South India[J]. Int J Stroke, 2021, 16(4):429-436. DOI: 10.1177/1747493020968236.
|
[23] |
MARTÍ-FÀBREGAS J, GUISADO-ALONSO D, DELGADO-MEDEROS R,et al. Impact of COVID-19 infection on the outcome of patients with ischemic stroke[J]. Stroke, 2021, 52(12):3908-3917. DOI: 10.1161/STROKEAHA.121.034883.
|
[24] |
BEKELIS K, MISSIOS S, AHMAD J,et al. Ischemic stroke occurs less frequently in patients with COVID-19:a multicenter cross-sectional study[J]. Stroke, 2020, 51(12):3570-3576. DOI: 10.1161/STROKEAHA.120.031217.
|
[25] |
LIN C, AREVALO Y A, NANAVATI H D,et al. Racial differences and an increased systemic inflammatory response are seen in patients with COVID-19 and ischemic stroke[J]. Brain Behav Immun Health, 2020, 8:100137. DOI: 10.1016/j.bbih.2020.100137.
|
[26] |
|
[27] |
PERRY R J, SMITH C J, ROFFE C,et al. Characteristics and outcomes of COVID-19 associated stroke:a UK multicentre case-control study[J]. J Neurol Neurosurg Psychiatry, 2021, 92(3):242-248. DOI: 10.1136/jnnp-2020-324927.
|
[28] |
JOHN S, HUSSAIN S I, PIECHOWSKI-JOZWIAK B,et al. Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic:a single center retrospective,observational study from the Abu Dhabi,United Arab Emirates[J]. Clin Neurol Neurosurg, 2020, 199:106227. DOI: 10.1016/j.clineuro.2020.106227.
|
[29] |
WANG M H, ZHANG H, HE Y Q,et al. Association between ischemic stroke and COVID-19 in China:a population-based retrospective study[J]. Front Med (Lausanne), 2021, 8:792487. DOI: 10.3389/fmed.2021.792487.
|
[30] |
CIOLLI L, RIGHI V, VANDELLI G,et al. In-hospital and out-of-hospital stroke in patients with COVID-19:two different diseases? [J]. Neurol Sci, 2022, 43(4):2203-2210. DOI: 10.1007/s10072-021-05807-w.
|
[31] |
GARCÍA-LAMBERECHTS E J, MIRÓ Ò, FRAGIEL M,et al. A case-control analysis of stroke in COVID-19 patients:results of unusual manifestations of COVID-19-study 11[J]. Acad Emerg Med, 2021, 28(11):1236-1250. DOI: 10.1111/acem.14389.
|
[32] |
KVERNLAND A, KUMAR A, YAGHI S,et al. Anticoagulation use and hemorrhagic stroke in SARS-CoV-2 patients treated at a New York healthcare system[J]. Neurocrit Care, 2021, 34(3):748-759. DOI: 10.1007/s12028-020-01077-0.
|
[33] |
BENUSSI A, PILOTTO A, PREMI E,et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia,Lombardy,Italy[J]. Neurology, 2020, 95(7):e910-920. DOI: 10.1212/WNL.0000000000009848.
|
[34] |
STAMM B, HUANG D, ROYAN R,et al. Pathomechanisms and treatment implications for stroke in COVID-19:a review of the literature[J]. Life (Basel), 2022, 12(2):207. DOI: 10.3390/life12020207.
|
[35] |
YANG Q H, TONG X, COLEMAN KING S,et al. Stroke hospitalizations before and during COVID-19 pandemic among medicare beneficiaries in the United States[J]. Stroke, 2021, 52(11):3586-3601. DOI: 10.1161/STROKEAHA.121.034562.
|
[36] |
TREJO-GABRIEL-GALÁN J M. Stroke as a complication and prognostic factor of COVID-19[J]. Neurol Engl Ed, 2020, 35(5):318-322. DOI: 10.1016/j.nrleng.2020.04.013.
|
[37] |
KATSANOS A H, PALAIODIMOU L, ZAND R,et al. The impact of SARS-CoV-2 on stroke epidemiology and care:a meta-analysis[J]. Ann Neurol, 2021, 89(2):380-388. DOI: 10.1002/ana.25967.
|
[38] |
GARCÍA-AZORÍN D, ABILDÚA M J A, AGUIRRE M E E,et al. Neurological presentations of COVID-19:findings from the Spanish Society of Neurology neuroCOVID-19 registry[J]. J Neurol Sci, 2021, 423:117283. DOI: 10.1016/j.jns.2020.117283.
|
[39] |
HOSSRI S, SHADI M, HAMARSHA Z,et al. Clinically significant anticardiolipin antibodies associated with COVID-19[J]. J Crit Care, 2020, 59:32-34. DOI: 10.1016/j.jcrc.2020.05.017.
|
[40] |
ZHANG A N, LENG Y, ZHANG Y,et al. Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19[J]. Int J Infect Dis, 2020, 100:441-448. DOI: 10.1016/j.ijid.2020.09.021.
|
[41] |
MILENKOVIC M, HADZIBEGOVIC A, KOVAC M,et al. D-dimer,CRP,PCT,and IL-6 levels at admission to ICU can predict in-hospital mortality in patients with COVID-19 pneumonia[J]. Oxid Med Cell Longev, 2022, 2022:8997709. DOI: 10.1155/2022/8997709.
|
[42] |
SINGH V, BEER A, KRAUS A,et al. Stroke increases the expression of ACE2,the SARS-CoV-2 binding receptor,in murine lungs[J]. Brain Behav Immun, 2021, 94:458-462. DOI: 10.1016/j.bbi.2021.01.039.
|
[43] |
JANARDHAN V, JANARDHAN V, KALOUSEK V. COVID-19 as a blood clotting disorder masquerading as a respiratory illness:a cerebrovascular perspective and therapeutic implications for stroke thrombectomy[J]. J Neuroimaging, 2020, 30(5):555-561. DOI: 10.1111/jon.12770.
|
[44] |
ROSAS I O, BRÄU N, WATERS M,et al. Tocilizumab in hospitalized patients with severe COVID-19 pneumonia[J]. N Engl J Med, 2021, 384(16):1503-1516. DOI: 10.1056/nejmoa2028700.
|
[45] |
NUTHALAPATI P, GHANTA M K, NATESH N S,et al. Association of hypercoagulation with severe acute respiratory syndrome coronavirus 2 infection[J]. Blood Res, 2021, 56(2):61-64. DOI: 10.5045/br.2021.2021011.
|
[46] |
AL-ANI F, CHEHADE S, LAZO-LANGNER A. Thrombosis risk associated with COVID-19 infection. A scoping review[J]. Thromb Res, 2020, 192:152-160. DOI: 10.1016/j.thromres.2020.05.039.
|
[47] |
ZAYET S, KLOPFENSTEIN T, KOVACS R,et al. Acute cerebral stroke with multiple infarctions and COVID-19,France,2020[J]. Emerg Infect Dis, 2020, 26(9). DOI: 10.3201/eid2609.201791.
|
[48] |
FLUMIGNAN R L, TINÔCO J D S, PASCOAL P I,et al. Prophylactic anticoagulants for people hospitalised with COVID-19[J]. Cochrane Database Syst Rev, 2020, 10:CD013739. DOI: 10.1002/14651858.CD013739.
|